Business Description
![Savara Inc Savara Inc logo](https://static.gurufocus.com/logos/0C0000099S.png?14)
Savara Inc
NAICS : 325412
SIC : 2834
ISIN : US8051111016
Description
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.39 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | -0.38 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 23.6 | |||||
3-Year EPS without NRI Growth Rate | 26.9 | |||||
3-Year FCF Growth Rate | 24.7 | |||||
3-Year Book Growth Rate | -5.1 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.34 | |||||
9-Day RSI | 62.24 | |||||
14-Day RSI | 59.37 | |||||
6-1 Month Momentum % | -3.16 | |||||
12-1 Month Momentum % | 28.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 14.9 | |||||
Quick Ratio | 14.9 | |||||
Cash Ratio | 14.58 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -36.6 | |||||
Shareholder Yield % | 0.11 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -54.21 | |||||
ROA % | -42.03 | |||||
ROIC % | -504.51 | |||||
ROC (Joel Greenblatt) % | -31436.26 | |||||
ROCE % | -47.83 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 5.61 | |||||
Price-to-Tangible-Book | 6.22 | |||||
EV-to-EBIT | -10.03 | |||||
EV-to-Forward-EBIT | -7.69 | |||||
EV-to-EBITDA | -10.06 | |||||
EV-to-FCF | -11.63 | |||||
Price-to-Net-Current-Asset-Value | 6.31 | |||||
Price-to-Net-Cash | 6.39 | |||||
Earnings Yield (Greenblatt) % | -9.97 | |||||
FCF Yield % | -7.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Savara Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.343 | ||
Beta | 0.39 | ||
Volatility % | 42.85 | ||
14-Day RSI | 59.37 | ||
14-Day ATR (€) | 0.223258 | ||
20-Day SMA (€) | 3.946 | ||
12-1 Month Momentum % | 28.67 | ||
52-Week Range (€) | 2.72 - 5.05 | ||
Shares Outstanding (Mil) | 164.44 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Savara Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Savara Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Savara Inc Frequently Asked Questions
What is Savara Inc(STU:YB4P)'s stock price today?
The current price of STU:YB4P is €4.54. The 52 week high of STU:YB4P is €5.05 and 52 week low is €2.72.
When is next earnings date of Savara Inc(STU:YB4P)?
The next earnings date of Savara Inc(STU:YB4P) is 2024-08-09 Est..
Does Savara Inc(STU:YB4P) pay dividends? If so, how much?
Savara Inc(STU:YB4P) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |